Eli Lilly & Co: Peers

The FY2024 (Dec) proxy of Eli Lilly & Co names 15 peer companies for pay. Among Eli Lilly & Co and these peers, CEO pay was the highest of 7 and total shareholder return was the highest of 7.

1st highest of 7in Eli Lilly & Co and its pay peers, FY2024 (Dec) by CEO pay:

$18.5M$29.2M

1st highest of 7in Eli Lilly & Co and its pay peers, FY2024 (Dec) by total shareholder return:

$52$627

Pay peer group, FY2024 (Dec) proxy

Pfizer
Amgen
Johnson & Johnson
Biogen
Bristol Myers Squibb
AbbVie
AstraZenecaNot disclosedNot disclosed
GileadNot disclosedNot disclosed
GlaxoSmithKlineNot disclosedNot disclosed
MerckNot disclosedNot disclosed
NovartisNot disclosedNot disclosed
Novo NordiskNot disclosedNot disclosed
RocheNot disclosedNot disclosed
SanofiNot disclosedNot disclosed
TakedaNot disclosedNot disclosed
15 companies

PSU comparator group

The companies that relative total shareholder return is measured against for performance stock units.

Johnson & Johnson
AbbVie
Pfizer
Amgen
Bristol Myers Squibb
Stryker
AstraZenecaNot disclosedNot disclosed
BiogenNot disclosedNot disclosed
GileadNot disclosedNot disclosed
GlaxoSmithKlineNot disclosedNot disclosed
MedtronicNot disclosedNot disclosed
MerckNot disclosedNot disclosed
NovartisNot disclosedNot disclosed
Novo NordiskNot disclosedNot disclosed
RocheNot disclosedNot disclosed
SanofiNot disclosedNot disclosed
TakedaNot disclosedNot disclosed
17 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.